CAH vs COR
CAH: Cardinal Health is a major healthcare services provider connecting manufacturers and healthcare providers through its extensive pharmaceutical and medical supply chain distribution network. COR: Cencora is a critical link in the global healthcare supply chain, providing pharmaceutical distribution, commercialization services, and specialty drug support to ensure patients have access to life-saving medications.
Side-by-side fundamentals
| Metric | CAH | COR | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $238.96 | $321.35 | |
| Market cap as of 2026-07-31 (share count; price 2026-10-08) | $55.6B | $61.3B | |
| P/E as of 2026-10-08 | 36.52 | 23.89 | COR lower |
| Net margin | +0.7% | +0.5% | CAH higher |
| Gross margin | +3.8% | +3.6% | CAH higher |
| Operating margin | +1.0% | +0.8% | CAH higher |
| ROE FY2025, SEC XBRL | n/a | +103.1% | |
| ROA | +3.0% | +2.0% | CAH higher |
| Debt / equity as of 2026-09-03 | 5.65 | 3.84 | COR lower |
| Revenue growth (YoY) as of 2026-09-03 | +12.9% | +5.1% | CAH higher |
| Revenue CAGR (3y) SEC XBRL | +7.4% | +10.4% | COR higher |
| Dividend yield as of 2026-09-03 | +0.9% | +0.8% | CAH higher |
| Dividend streak (yrs) SEC XBRL | 19 | 4 | CAH higher |
| Beta as of 2026-09-03 | 0.27 | -0.03 | |
| 1-year return as of 2026-10-08 close | +51.5% | +3.5% | CAH higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.